Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Patanjali claims research shows success treating psoriasis using Sorogrit and Divya oil. Acharya Balkrishna highlights ...

About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a diverse range of therapeutic alternatives for treatment ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Medically reviewed by Brendan Camp, MD Many people with psoriasis successfully undergo cosmetic procedures, but they should avoid treatments done directly on psoriasis lesions or during flare-ups, as ...

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed.